Significant Impact of Implantable Functional Electrical Stimulation on Gait Parameters: A Kinetic Analysis in Foot Drop Patients.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 27 10 2018
revised: 06 03 2019
accepted: 07 03 2019
pubmed: 8 4 2019
medline: 22 1 2020
entrez: 8 4 2019
Statut: ppublish

Résumé

Neurogenic drop foot is a common result of acquired damage of the central nervous system and can cause severe restriction of mobility. ActiGait, an implantable functional electrical stimulation device, restores ankle dorsiflexion by active peroneal nerve stimulation. The aim of our study was to evaluate its effect on foot contact pattern during normal walk. Eight patients with drop foot who used ActiGait in everyday life performed a 20-meter comfortable walk test. Gait parameters were evaluated with an insole system (Medilogic). Percentage of biped stance in a double-step, effective foot length, width of gait, and overall plantar load were measured in comparison with and without activated drop foot stimulation. Effective foot length increased in all patients on average from 46.0% to 60.2% (P = 0.038). However, percentage of biped stance in a double-step showed no significant difference (31.2% vs. 27.8% on average, P = 0.063), nor did width of gait (2.6% vs. 2.4% on average, P = 0.73) and overall plantar load (3.51 N/cm The ActiGait implantable drop foot stimulator significantly improves effective foot length during normal walk of patients with neurogenic drop foot. Further investigation is needed to confirm whether ActiGait has no effect on the other parameters or whether it facilitates permanent gait adaptations that persist without the activated device.

Identifiants

pubmed: 30954755
pii: S1878-8750(19)30712-0
doi: 10.1016/j.wneu.2019.03.064
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e236-e241

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Jörn Bucklitsch (J)

ProFuß GmbH, Frankfurt am Main, Germany.

Andreas Müller (A)

ProFuß GmbH, Frankfurt am Main, Germany.

Albert Weitner (A)

Orthopädietechnik Weitner, Frankfurt am Main, Germany.

Natalie Filmann (N)

Institut für Biostatistik und Mathematische Modellierung, Klinikum und Fachbereich Medizin der Goethe-Universität, Frankfurt am Main, Germany.

Andrei Patriciu (A)

nstim Services GmbH, Vienna, Austria.

Bedjan Behmanesh (B)

Klinik und Poliklinik für Neurochirurgie der Goethe-Universität, Frankfurt am Main, Germany.

Volker Seifert (V)

Klinik und Poliklinik für Neurochirurgie der Goethe-Universität, Frankfurt am Main, Germany.

Gerhard Marquardt (G)

Klinik und Poliklinik für Neurochirurgie der Goethe-Universität, Frankfurt am Main, Germany.

Johanna Quick-Weller (J)

Klinik und Poliklinik für Neurochirurgie der Goethe-Universität, Frankfurt am Main, Germany. Electronic address: johanna.quick@gmx.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH